How fragile is the distribution network for the UK's COVID-19 vaccination programme?
The news of potentially successful coronavirus vaccines has provided welcome light amid the gloom of continued lockdowns and restrictions. Announcements from Moderna, AstraZeneca and Pfizer/BioNTech of candidate vaccines with efficacy above 90% have seen stock markets soar and hopes grow that, by autumn 2021, the world might see a return to a more ‘normal’ existence.